STOCK TITAN
  1. Home
  2. News
  3. KIDS

OrthoPediatrics Corp. - KIDS STOCK NEWS

Welcome to our dedicated page for OrthoPediatrics news (Ticker: KIDS), a resource for investors and traders seeking the latest updates and insights on OrthoPediatrics stock.

OrthoPediatrics Corp. (symbol: KIDS) is a global leader in pediatric orthopedics, exclusively focusing on providing innovative solutions for children with orthopedic conditions and injuries. The company is dedicated to advancing pediatric orthopedics by developing state-of-the-art technologies, ensuring high-quality products, and offering unparalleled support and clinical education through its team of experts.

OrthoPediatrics offers a wide range of anatomically appropriate implants and instruments designed to meet the unique needs of pediatric orthopedic surgeons. Their product portfolio includes solutions for long bone deformity correction and trauma, spine, and sports medicine. Among their flagship products are PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia, and the ACL Reconstruction System.

Recent achievements of OrthoPediatrics include issuing the 2024 financial guidance and recording a full-year revenue of $148.7 million in 2023, marking a 22% increase compared to the previous year. As of December 31, 2023, the company had cash and cash equivalents, short-term investments, and restricted cash totaling $82.3 million. The recent acquisition of Boston Orthotics & Prosthetics was a significant milestone, further reinforcing their market position.

In the first quarter of 2024, OrthoPediatrics reported a 41% increase in revenue year-over-year. The company's total other expense was $0.6 million for the quarter, primarily due to a favorable fair value adjustment in the previous year that did not recur in 2024, as well as additional interest expenses related to a new term loan with MidCap. As of March 31, 2024, the company's cash, cash equivalents, short-term investments, and restricted cash were $49.7 million.

OrthoPediatrics continues to seek talented professionals to join their mission. Interested candidates can visit their website to learn about current openings or submit their resumes to careers@orthopediatrics.com. For the latest updates, news, and developments, shareholders and potential investors can find the most recent information on OrthoPediatrics Corp. through this page.

News

OrthoPediatrics Corp. Announces Launch of Specialty Bracing Division

Rhea-AI Summary
OrthoPediatrics Corp. (Nasdaq: KIDS) announced the launch of its new division, OrthoPediatrics Specialty Bracing division (OPSB), focusing on non-surgical intervention for pediatric orthopedics. The division aims to expand the Company’s Total Addressable Market by approximately $600 million, following the acquisition of MD Orthopaedics, Inc. (MDO) and Rhino Pediatric Orthopedic Designs, Inc. The Company also introduced the DF2® Brace and partnered with Ora Medical to distribute The Levity, a gait-trainer device for children with walking difficulties.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.44%
Tags
none
-
News

OrthoPediatrics Corp. to Host Educational and Networking Events at 19th Annual International Pediatric Orthopaedic Symposium (IPOS)

Rhea-AI Summary
OrthoPediatrics Corp. (Nasdaq: KIDS) increases its support of IPOS as an Emerald-Level sponsor, showcasing its expanding product portfolio at the event. Over 500 pediatric orthopedic surgeons are registered to attend the meeting from December 5-9, in Orlando, Florida. The company aims to connect with its surgeon customers and continue to partner with them in education, emphasizing its commitment to advancing the field of pediatric orthopedics.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.77%
Tags
conferences
-
News

OrthoPediatrics Corp. to Participate in Upcoming November Conferences

Rhea-AI Summary
OrthoPediatrics Corp. (NASDAQ: KIDS) announces participation in fireside chats at Stifel 2023 Healthcare Conference and Piper Sandler 35th Annual Healthcare Conference. The company's President & CEO and COO/CFO will discuss at the events, with audio webcasts and replays available online at the OrthoPediatrics investor relations website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.67%
Tags
conferences
News

OrthoPediatrics Corp. Reports Third Quarter 2023 Financial Results

Rhea-AI Summary
OrthoPediatrics Corp. reported record-setting quarterly revenue of $40.0 million, a 14% increase compared to the same period last year. The company helped over 22,000 children in Q3 2023, bringing the total to over 692,000 since inception. Adjusted EBITDA reached $3.6 million, up from $1.9 million in Q3 2022. OrthoPediatrics launched new products, including the Pediatric Nailing Platform TIBIA system and the DF2 Brace. The company reiterated its full-year 2023 revenue guidance of $148.0 million to $151.0 million, representing 21% to 23% growth compared to the prior year.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.19%
Tags
earnings
-
News

OrthoPediatrics Corp. Enters Distribution Agreement with Ora Medical

Rhea-AI Summary
OrthoPediatrics Corp. has entered into an exclusive Distribution Agreement with Ora Medical to sell The Levity, a gait trainer for children with walking difficulties. The device features a personalized treatment, adjustable features, and a foldable design. The partnership aims to improve the mobility of children globally.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.01%
Tags
none
-
News

OrthoPediatrics Corp. Launches MP+ Bar for Clubfoot

Rhea-AI Summary
OrthoPediatrics Corp. has announced the limited release of the Mitchell Ponseti Plus Bar (MP+) as part of their Specialty Bracing portfolio for kids with clubfoot. The new MP+ Bar features several innovations and enhancements compared to their traditional Bar. The company is also developing the MP Lite boots & bar system for markets outside the United States. OrthoPediatrics plans to continue launching new innovative products to address the large unmet needs in the pediatric orthopedic market.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.7%
Tags
none
News

OrthoPediatrics Corp. Launches Pediatric Nailing Platform | Tibia

Rhea-AI Summary
OrthoPediatrics Corp. announces the release of the Pediatric Nailing Platform TIBIA system and successful completion of the first cases.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.55%
Tags
none
-
News

OrthoPediatrics Corp. to Report Third Quarter 2023 Financial Results on November 7, 2023

Rhea-AI Summary
OrthoPediatrics Corp. to release third quarter 2023 financial results
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.67%
Tags
conferences earnings
-
News

OrthoPediatrics Joins Alliance for Pediatric Device Innovation

Rhea-AI Summary
OrthoPediatrics Corp. announces strategic partnership with Children’s National Hospital for pediatric device innovation
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.69%
Tags
none
News

OrthoPediatrics Corp. Launches DF2 Brace®

Rhea-AI Summary
OrthoPediatrics Corp. announces limited release of DF2® Brace for treating pediatric femur fractures.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.53%
Tags
none

FAQ

What is the current stock price of OrthoPediatrics (KIDS)?

The current stock price of OrthoPediatrics (KIDS) is $26.34 as of November 22, 2024.

What is the market cap of OrthoPediatrics (KIDS)?

The market cap of OrthoPediatrics (KIDS) is approximately 637.8M.

What does OrthoPediatrics Corp. do?

OrthoPediatrics Corp. designs, develops, and commercializes implants and instruments specifically for pediatric orthopedic surgeons to treat children with orthopedic conditions and injuries.

What are some of OrthoPediatrics' key products?

Key products include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia, and the ACL Reconstruction System.

What were OrthoPediatrics' financial highlights for 2023?

OrthoPediatrics recorded a full-year revenue of $148.7 million in 2023, a 22% increase compared to the prior year.

How did OrthoPediatrics perform in the first quarter of 2024?

In the first quarter of 2024, OrthoPediatrics reported a 41% increase in revenue year-over-year, with total other expense at $0.6 million.

What recent acquisition did OrthoPediatrics make?

OrthoPediatrics recently acquired Boston Orthotics & Prosthetics, further reinforcing their market position.

How much cash and equivalents did OrthoPediatrics have as of March 31, 2024?

As of March 31, 2024, OrthoPediatrics had $49.7 million in cash, cash equivalents, short-term investments, and restricted cash.

What is OrthoPediatrics' focus in pediatric orthopedics?

OrthoPediatrics focuses on advancing pediatric orthopedics by developing state-of-the-art technologies, high-quality products, and offering industry-leading support and clinical education.

Where can I learn about career opportunities at OrthoPediatrics?

You can learn about current openings and career opportunities at OrthoPediatrics by visiting their website or submitting a resume to careers@orthopediatrics.com.

Who can I contact for investor relations at OrthoPediatrics?

For investor relations, you can contact Philip Taylor at Gilmartin Group via email at philip@gilmartinir.com or phone at 415-937-5406.

What recent financial guidance did OrthoPediatrics issue?

OrthoPediatrics recently issued their 2024 financial guidance, which includes detailed projections and expectations for the year.

Stock KIDS logo
OrthoPediatrics Corp.

Nasdaq:KIDS

KIDS Rankings

#2922 Ranked by Market Cap
N/A Ranked by Dividends

KIDS Stock Data

637.85M
16.34M
32.52%
70.85%
3.77%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
WARSAW